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Sema4D, the Ligand for Plexin B1, Suppresses c-Met
Activation and Migration and Promotes Melanocyte
Survival and Growth
Joanne Soong1,2, Yulin Chen2, Elina M. Shustef2 and Glynis A. Scott1,2
Semaphorins are secreted and membrane-bound proteins involved in neural pathfinding, organogenesis, and
tumor progression, through Plexin and neuropilin receptors. We recently reported that Plexin B1, the
Semaphorin 4D (Sema4D) receptor, is a tumor-suppressor protein for melanoma, which functions, in part,
through inhibition of the oncogenic c-Met tyrosine kinase receptor. In this report, we show that Sema4D is
a protective paracrine factor for normal human melanocyte survival in response to UV irradiation, and that it
stimulates proliferation and regulates the activity of the c-Met receptor. c-Met receptor signaling stimulates
melanocyte migration, partly through downregulation of the cell adhesion molecule E-cadherin. Sema4D
suppressed activation of c-Met in response to its ligand, hepatocyte growth factor (HGF), and partially blocked
the suppressive effects of HGF on E-cadherin expression in melanocytes and HGF-dependent migration.
These data demonstrate a role for Plexin B1 in maintenance of melanocyte survival and proliferation in the skin,
and suggest that Sema4D and Plexin B1 act cooperatively with HGF and c-Met to regulate c-Met-dependent
effects in human melanocytes. Because our data show that Plexin B1 is profoundly downregulated by UVB
in melanocytes, loss of Plexin B1 may accentuate HGF-dependent effects on melanocytes, including melanocyte
migration.
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INTRODUCTION
Semaphorins are secreted or membrane bound proteins, and
were originally described in the nervous system, but are also
expressed in multiple organs, including the lung, kidney,
bone, and lymph tissue (Takegahara et al., 2005; Yazdani and
Terman, 2006). Plexins, the transmembrane receptors for
Semaphorins, are a family of highly conserved proteins that
alone or in cooperation with neuropilins mediate the effects
of Semaphorins (Tamagnone and Comoglio, 2000; Castellani
and Rougon, 2002; Puschel, 2002; Fujisawa, 2004). The
Plexin B1 receptor binds Semaphorin 4D (Sema4D), a class
IV Semaphorin whose functions include neovascularization
of tumors, axon guidance, and immune regulation (Elhabazi
et al., 2003; Ch’ng and Kumanogoh, 2010). Sema4D is
cleaved by matrix metalloproteinases and is active in a
membrane-bound and soluble form (Basile et al., 2007;
Zhu et al., 2007). Plexin B1 has R-Ras and M-Ras GTPase
activity (Oinuma et al., 2004; Negishi et al., 2005; Saito
et al., 2009), and activates mitogen-activated protein kinase
via Rho and integrin activation (Aurandt et al., 2006; Oinuma
et al., 2006). Plexin B1 activation by Sema4D also
participates in c-Met and ErbB receptor activation (Giordano
et al, 2002; Conrotto et al., 2004; Wickramasinghe and Kong-
Beltran, 2005; Swiercz et al., 2008).
Melanocytes are critically important in the skin because
they produce the pigment melanin, mitigating the effects
of photoaging and photocarcinogenesis (Bhawan et al.,
1992; Tadokoro et al., 2003; Wulf et al., 2004). Many
functions of melanocytes are regulated, in part, by growth
factors produced by keratinocytes (Yaar et al., 1991; Tada
et al., 1998; Imokawa, 2004; Cardinali et al., 2005), or by the
melanocytes themselves (Abdel-Malek et al., 1999; Starner
et al., 2010). A potentially important role for Plexin B1 in
melanocytes is suggested by recent reports showing that
Plexin B1 is a tumor-suppressor protein for melanoma
(Argast et al., 2009; Stevens et al., 2010). Plexin B1
expression is lost in melanoma in vivo, particularly in deeply
invasive and metastatic tumors (Stevens et al., 2010), and
introduction of Plexin B1 into human melanoma cell lines
abrogates metastasis in a mouse model (Argast et al., 2009).
Although the mechanism by which Plexin B1 suppresses
melanoma progression is still being defined, we showed
that Plexin B1 signaling blocks activation of the tyrosine
kinase receptor c-Met by its ligand, hepatocyte growth factor
(HGF) (Stevens et al., 2010). c-Met controls multiple aspects
of melanocyte function in response to HGF, which is
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upregulated by UV irradiation in keratinocytes and fibroblasts
(Brenner et al., 2005; Mildner et al., 2007). c-Met signaling
suppresses expression of E-cadherin in melanocytes, mela-
noma, and other cell types, and loss of E-cadherin contri-
butes to melanocyte migration and progression of melanoma
(Danen et al., 1996; Davies et al., 2001; Li et al., 2001;
Desiderio, 2007).
In this report, we examined the function of Plexin B1
in normal human melanocytes and the expression of Sema4D
in the skin. Our data point to a role for Plexin B1 in
melanocyte survival and proliferation, and suggest that
loss of Plexin B1 may promote early stages of melanoma
formation through enhanced c-Met activation, resulting in
loss of E-cadherin expression and increased c-Met-dependent
migration.
RESULTS
Sema4D and Plexin B1 are expressed in the skin in vivo
Immunocytochemical staining of skin shows strong expres-
sion of Sema4D in basal keratinocytes, closely apposed to
melanocytes, which also expressed Sema4D, although
weakly (Figure 1a and b); Sema4D was detected in dermal
fibroblasts (not shown), lymphocytes (Figure 1c), smooth
muscle of blood vessels (Figure 1d), and nerves (Figure 1e),
but not in endothelial cells. Keratinocytes and melanocytes
expressed Sema4D in vitro (Figure 1f). Immunocytochemical
staining of skin showed strong diffuse expression of Plexin B1
in keratinocytes throughout all layers of the epidermis (Figure
1g). As previously reported, melanocytes express Plexin B1
in vivo (Figure 1h), as do endothelial cells (Stevens et al.,
2010). Smooth muscle of blood vessels and pilierector
muscles also expressed Plexin B1 (Figure 1i). Western
blotting of melanocyte and keratinocytes showed a band of
the expected size (B225 kDa) in both cell types (Figure 1j) for
Plexin B1, as well as a lower band (B190 kDa) likely
representing the proteolytically processed receptor (Artigiani
et al., 2003). In some cases, a predominant band of
B100 kDa was observed in melanocytes, as previously
reported (Stevens et al., 2010).
We next determined whether UVB regulates Plexin B1 in
melanocytes (Figure 2). Message levels of Plexin B1 were
lowered by 25 and 50%, 18 hours after 25 and 50mJ cm–2
UVB, respectively, compared with sham-irradiated controls.
At 24 hours after irradiation, Plexin B1 at the protein level
decreased 50% (25mJ cm–2) and 75% (50mJ cm–2) compared
with sham-irradiated controls. UVB had no effect on Plexin
B1 expression in keratinocytes or on Sema4D expression in
melanocytes (data not shown).
Sema4D is a survival factor for melanocytes
To determine whether Sema4D protects melanocytes from
UVB-induced apoptosis, melanocytes were placed in basal
medium overnight, and were pretreated with Sema4D
(500 ngml–1) for 8 hours, and then irradiated with UVB. The
medium was replaced with fresh Sema4D; 18 hours later,
floating cells were collected and combined with adherent
cells, and levels of cleaved (activated) caspase-3 were
determined by western blot analysis (Figure 3a). Sema4D
abrogated UV-dependent caspase-3 activation at both doses
of UVB by 430%. We knocked down Plexin B1 expression
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Figure 1. Semaphorin 4D (Sema4D) and Plexin B1 are expressed in the skin. (a) Basal keratinocytes strongly express Sema4D (bar¼ 10 mm). (b) Melanocytes,
characterized by perinuclear halos, also express Sema4D (arrows, inset). (c) Lymphocytes, (d) smooth muscle, and (e) cutaneous nerves (arrows) express
Sema4D. (f) Total cell lysates of melanocytes (MCs) and keratinocytes (KCs) were blotted for Sema4D (80 mg loaded; 7.5% SDS-PAGE). A band of the expected
size is detected in both cell types (representative of four experiments). Positive control (þ ) is a human squamous cell carcinoma cell line. The lower band
(B120 kDa) likely represents the proteolytically cleaved portion of the protein. (g) Plexin B1 is expressed throughout all layers of the epidermis (bar¼ 50 mm).
Endothelial cells (asterisks) express Plexin B1, as do melanocytes (h: inset). (i) Smooth muscles of pili-erector apparatus also express Plexin B1. (j) Total cell
lysates of MCs and KCs were resolved on 7.5% SDS-PAGE and blotted for Plexin B1 (40 mg loaded). A band of the expected size is detected in both cell
types (representative of four experiments).
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in melanocytes and examined apoptosis by TUNEL assay in
response to UVB. Plexin B1 knockdowns demonstrated
significantly (Po0.01) more apoptosis in sham-irradiated
cells compared with nontarget controls, which was further
increased by irradiation (Figure 3b), in the absence of
exogenous Sema4D. Growth factor–dependent activation of
Akt suppresses apoptosis in melanocytes (Larribere et al.,
2004; Oka et al., 2004; Kadekaro et al., 2005). Sema4D
transiently induced Akt activation in serum-starved nontarget
controls, which peaked at 10minutes. Knockdown of Plexin
B1 completely blocked Sema4D-dependent Akt activation,
indicating that Sema4D activates Akt through Plexin B1
(Figure 3c).
Plexin B1 signaling promotes melanocyte proliferation
Plexin B1 knockdowns grew very slowly, suggesting
that Plexin B1 stimulates melanocyte proliferation. To test
this, Plexin B1 knockdowns, or nontarget controls, were
placed in basal medium for 8 hours, and then treated
with Sema4D (100 ngml–1) for 18 hours, and proliferation
was assessed by CLICK-IT assay (Figure 4a). Proliferation was
significantly lower in Plexin B1 knockdowns compared with
cells expressing nontarget short hairpin RNA (shRNA), even
in the absence of Sema4D. The addition of Sema4D modestly
increased proliferation in nontarget controls, but this did not
reach statistical significance, suggesting autocrine effects of
Sema4D. Analysis of extracellular signal–regulated kinase 1
and 2 (Erk1/Erk2) activation in response to Sema4D was
performed in Plexin B1 knockdowns. Treatment of nontarget
controls with Sema4D activated Erk1/Erk2, which peaked at
10minutes (Figure 4b). Plexin B1 knockdowns showed lower
basal levels of activated Erk1/Erk2, consistent with their
low proliferative rate under resting conditions, and delayed
and lower levels of Erk1/Erk2 activation in response to
Sema4D compared with nontarget controls. Lack of complete
blockade of Erk1/Erk2 activation in Plexin B1 knockdowns
may be secondary to incomplete knockdown of the receptor
(Supplementary Figure S1 online).
Sema4D blocks c-Met activation
To determine whether Sema4D blocks c-Met activation
in melanocytes, cells were placed in basal medium over-
night, pretreated with Sema4D (100 ngml–1) for 30minutes,
and then treated with HGF (10 ngml–1 for 15minutes) in
the presence of Sema4D or control Sema4D (Figure 5a).
Cells treated with HGF in the presence of control Sema4D
stimulated c-Met phosphorylation 2.5-fold. In contrast,
c-Met phosphorylation was only 1.8-fold in cells treated
with Sema4D and HGF, a difference that was significant
(Po0.05). Treatment of melanocytes with Sema4D alone had
no effect on c-Met activity (Supplementary Figure S1 online),
similar to what we observed in melanoma (Stevens et al.,
2010). Silencing of Plexin B1 blocked the effects of Sema4D
on HGF-dependent c-Met activation, and resulted in higher
basal levels of activated c-Met (Figure 5b).
HGF stimulates melanocyte migration, in part through
downregulation of E-cadherin expression (Li et al, 2001;
Han et al., 2005). We next determined whether Sema4D
abrogates the effects of HGF on E-cadherin expression and
migration. A dose response for HGF-dependent suppression
of E-cadherin showed that doses as low as 5 ngml–1 com-
pletely suppressed E-cadherin expression in melanocytes
(Supplementary Figure S2 online). We next treated melano-
cytes with HGF (10 ngml–1) in the presence of Sema4D
(100 ngml–1) for 24 hours, and E-cadherin levels were
analyzed (Figure 5c). Sema4D partially restored E-cadherin
expression in melanocytes in response to HGF. We next
determined whether Sema4D blocks HGF-dependent migra-
tion of melanocytes (Figure 5d). Melanocytes were grown to
80% confluence in six-well dishes, and migration was
quantified by scratch assay at 24 hours. As expected,
HGF (10 ngml–1) stimulated melanocyte migration with an
average fold increase of 4.36 (±1.72 SD) compared with
vehicle-treated cells. In contrast, in cells treated with HGF
and Sema4D (100 ngml–1), migration was only 1.2-fold
more (±0.75 SD) compared with vehicle-treated cells.
The difference in fold change in migration between HGF/
control and HGF/Sema4D-treated cells was significant
(P¼0.04, n¼3). Sema4D alone (100 ngml–1) had no effect
on melanocyte migration.
DISCUSSION
We were motivated to conduct this study because
Plexin B1 is a newly recognized tumor-suppressor protein
Plexin B1 western blot
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Figure 2. UVB downregulates Plexin B1 in melanocytes. Melanocytes (MCs)
were irradiated with UVB, or sham irradiated, and 18 hours later Plexin B1
was assessed by real-time PCR. Matched cultures were irradiated and Plexin
B1 protein was measured 24 hours later by western blotting. The bar graph
shows the average percent decrease in Plexin B1 mRNA compared with
sham-irradiated cells,±SD (average of four cultures). The western blot shows
lysates from a representative culture resolved on 7.5% SDS-PAGE and blotted
for Plexin B1. The numbers beneath the blot indicate the percent decrease in
Plexin B1 expression, normalized to b-actin.
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for melanoma (Argast et al., 2009; Stevens et al., 2010).
Understanding the function of this receptor in melanocytes
could provide insight into how loss of the receptor promotes
melanoma initiation or progression. In this report, we show
that Plexin B1 expression is regulated by UVB in melano-
cytes, and that Plexin B1 signaling contributes to melanocyte
growth and survival. Of particular interest was the observa-
tion that, similar to melanoma, Plexin B1 signaling suppresses
c-Met activation and migration in response to HGF. Knock-
down of Plexin B1 increased basal levels of c-Met activation,
suggesting that chronic loss of Plexin B1 may promote
HGF-dependent migration and, potentially, early stages of
melanoma progression through enhanced c-Met activity.
Sema4D is expressed by keratinocytes in vivo, suggesting
that Sema4D is a paracrine factor for melanocytes. Because
Sema4D stimulates angiogenesis, T-cell activation, and B-cell
aggregation and viability, it may participate in new vessel
formation or immune function in the skin, through effects on
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Figure 3. Semaphorin 4D (Sema4D) protects melanocytes from apoptosis in response to UVB. (a) Sema4D (þ S4D; 500 ngml–1) abrogated UVB-dependent
caspase-3 activation. Shown are total cell lysates of melanocytes resolved on 10% SDS-PAGE and blotted for active caspase-3. Results are representative
of four separate experiments. Densitometry analysis of averaged (n¼ 4 experiments) caspase-3 levels normalized to b-actin are shown. (b) Representative images
of TUNEL staining of Plexin B1 knockdowns (KD) or controls (nontarget short hairpin RNA (shRNA-NT)) following UVR. Plexin B1 knockdowns show markedly
higher levels of apoptosis, as shown by TUNEL-positive nuclei (arrows), in the absence of ligand. Following UVB, a striking increase in TUNEL-positive
nuclei in Plexin B1 knockdowns was seen, compared with nontarget controls. Quantification of TUNEL-positive nuclei from melanocyte cultures silenced for
Plexin B1 (823A and 824A) show highly significant differences compared with shRNA-NT controls. Each column represents the average of three separate
experiments±SD. *P¼ 0.001; **P¼0.0001; ***P¼ 0.0013. (c) Treatment of melanocytes with Sema4D (500 ngml–1) stimulated Akt phosphorylation in control
cells (shRNA-NT) but not in Plexin B1 knockdowns. Basal levels of phospho-Akt are lower in Plexin B1–silenced cells (arrows). Shown are total cellular
lysates resolved on a 10% SDS-PAGE. Results are representative of three experiments.
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vascular endothelium and lymphocytes. Sema4D was also
expressed, although at lower levels, by melanocytes in vivo
and in vitro. In our previous report (Stevens et al., 2010), we
did not identify Sema4D in melanocytes by western blotting.
In this report, we were able to uncover expression by loading
a larger amount of protein (80–100 mg). Because of abundant
expression of Sema4D by basal keratinocytes, it is likely that
Sema4D is primarily a paracrine factor for melanocytes
in vivo, although some autocrine effects may occur. Sema4D
is released as an active product through the action of matrix
metalloproteinases (Basile et al., 2007); therefore, Sema4D
from fibroblasts may function as a secreted paracrine factor
for melanocytes, particularly following UV irradiation, which
activates matrix metalloproteinases (Brenneisen et al, 1996).
Sema4D protected melanocytes from UV-dependent
apoptosis, as indicated by lower levels of cleaved caspase-3
in Sema4D-treated cells, similar to the effects of a-melano-
cyte-stimulating hormone on UV-dependent apoptosis in
melanocytes (Bohm et al., 2005; Kadekaro et al., 2005). Akt is
a major effector of growth factor–dependent cell survival
and was transiently activated by Sema4D in melanocytes.
Whether transient activation of Akt by Sema4D has a role in
protecting melanocytes from UVB-dependent apoptosis
remains to be determined, but in human keratinocytes,
short-term (1–2 hours) activation of Akt by IGF-1 delays the
onset of UVB-dependent apoptosis at 48 hours (Decraene
et al., 2002). A similar pathway may be involved in the
protective effects of Sema4D on apoptosis in response to
UVB in melanocytes. In melanoma, Plexin B1 signaling also
activates Akt and protects melanoma from apoptosis induced
by cis-platin (Stevens et al., 2010). Therefore, Akt is a shared
target of Plexin B1 in melanocytes and melanoma. Silencing
of Plexin B1 profoundly inhibited proliferation in the absence
of added Sema4D, suggesting potential autocrine effects, and
treatment of melanocytes with Sema4D activated Erk1/Erk2
in a Plexin B1–dependent manner, consistent with a pro-
proliferative effect of Plexin B1. In contrast, melanoma cell
lines reconstituted with Plexin B1 proliferated slower than
LacZ controls (Stevens et al., 2010). Therefore, fundamental
differences in Plexin B1 signaling on downstream pathways
that control proliferation exist in melanocytes and melanoma.
Our data show that Sema4D suppresses c-Met activation
by HGF and partially blocks HGF-dependent E-cadherin
downregulation and migration in melanocytes. Because Akt
and Erk1/Erk2 are well-known targets of c-Met, we tested the
ability of Sema4D to suppress HGF-dependent Akt and Erk1/
Erk2 phosphorylation, but did not observe detectable changes
in activation of these targets (Scott Laboratory, unpublished
data). This may be because Plexin B1 and c-Met both activate
Akt and Erk1/Erk2, masking the suppressive effects of
Sema4D on HGF-dependent phosphorylation of these targets.
Silencing of Plexin B1 blocked the inhibitory effect of
Sema4D on HGF-dependent c-Met phosphorylation, and
increased basal levels of activated c-Met, indicating that
Plexin B1 is necessary for regulation of c-Met activity. The
observation that basal levels of active c-Met are higher in
Plexin B1 knockdowns suggests that autocrine production of
Sema4D regulates the activity of c-Met in normal melano-
cytes. Alternatively, chronic loss of Plexin B1 may lead to
compensatory changes resulting in activation of c-Met,
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independent of ligand. The mechanism by which Plexin B1
inhibits c-Met activation in melanocytes remains to be
defined. Several ‘‘co-receptors’’ for c-Met activation have
been identified, including the adhesion molecules CD44v6
(Matzke et al., 2007) and ICAM-1 (Olaku et al., 2011), EGFR
(Bergstrom et al., 2000), and neuropilin-1 and neuropilin-2
(Sulpice et al., 2008), which potentiate the activation of
c-Met. To our knowledge, Plexin B1 is the first receptor
identified that stimulates and inhibits c-Met activation in a
cell-type-specific manner. Because Plexin B1 shares signifi-
cant homology with c-Met, it may compete with c-Met
for binding to HGF, similar to neuropilin receptors (Sulpice
et al., 2008). Alternatively, Plexin B1 may form a complex
with c-Met, preventing tyrosine phosphorylation of residues
necessary for docking of adaptor proteins necessary for
c-Met downstream effects, such as migration. The mechanism
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Sema4D (100 ngml–1). Cells treated with Sema4D (S4D) alone are also shown (bottom). Melanocytes treated with HGF/control show more cells migrating into
the scratch area (arrows), compared with cells treated with HGF/Sema4D. Sema4D alone had no effect on migration. Each column represents the averaged
number of cells migrated into the scratch±SD. The graph to the right shows the average fold change in migration from three experiments, with vehicle-treated
cells set as ‘‘1’’ (±SD). Differences in fold change between HGF/C-treated cells and HGF/Sema4D-treated cells are significant (P¼ 0.04).
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by which Plexin B1 receptor signaling inhibits c-Met activa-
tion and cell migration will be the focus of a separate report.
In our proposed model (Figure 6), we predict that Plexin
B1 signaling in melanocytes is activated through Sema4D
produced by basal keratinocytes and melanocytes, promoting
survival and proliferation. Plexin B1 maintains a brake on
c-Met signaling, and maintains levels of E-cadherin expres-
sion. Following irradiation, HGF production by keratinocytes
and fibroblasts is increased (Brenner et al., 2005; Mildner
et al., 2007) and Plexin B1 expression in melanocytes is
suppressed, resulting in enhanced c-Met activity and loss of
E-cadherin expression. Because loss of E-cadherin is an early
event in transformation of melanocytes to melanoma, Plexin
B1 could function as a tumor-suppressor protein for early
stages of melanoma by blocking the effects of c-Met signaling
on E-cadherin expression and melanocyte migration.
MATERIALS AND METHODS
Reagents
PureCol was obtained from Inamed Biomaterials (Freemont, CA); the
BCA Protein Assay kit was obtained from Pierce Chemical (Rockford,
IL). Rabbit polyclonal antibodies to b-actin were purchased from
Santa Cruz Biotechnologies (Santa Cruz, CA); rabbit polyclonal
antibodies to Plexin B1 were purchased from ECM Biosciences
(Versailles, KY). Mouse mAbs to Sema4D were purchased from BD
Transduction Laboratories (Sparks, MD). Mouse mAbs to c-Met,
rabbit mAbs to phospho-Met (Y-1234/Y-1235), rabbit mAbs to
phospho-AKT and total AKT, rabbit mAbs to phospho-Erk1/Erk2,
mouse mAbs to total Erk1/Erk2, and rabbit mAbs to caspase-3 were
purchased from Cell Signaling Technology (Danvers, MA). Anti-
bodies against E-cadherin were purchased from R&D systems
(Minneapolis, MN). Horseradish peroxidase–conjugated goat
anti-rabbit and goat anti-mouse antibodies and hepatocyte growth
factor were purchased from Sigma (St Louis, MO). Full-range
rainbow molecular weight marker was purchased from Amersham
Life Sciences (Arlington Heights, IL). Polybrene was purchased from
Santa Cruz Biotechnologies.
Cells and cell culture
Neonatal foreskins were obtained according to the University of
Rochester Research Subjects Review Board guidelines and were the
source of cultured human melanocytes and keratinocytes. Human
melanocytes were cultured in Opti-MEM (Gibco-BRL, Grand Island,
NY) containing 5% fetal bovine serum (Atlanta Biologicals, Law-
renceville, GA), 104M iso-butyl-methylxanthine, Anti-Anti (Gibco-
BRL), 2.5 nM cholera toxin, 0.1mM dibutyryl cyclic AMP, and
25ngml–1 phorbol ester. Keratinocytes were cultured in Keratinocyte
Serum-Free Media (Gibco-BRL). All supplements, except fetal bovine
serum and Anti-Anti, were purchased from Sigma. With the exception
of scratch assays and experiments in which Plexin B1–silenced cells
were used, pooled cultures of melanocytes initiated from two to three
foreskins were used at passages 4–8. Each experiment was repeated at
least three times with separate pooled cultures of cells.
Silencing of Plexin B1 in human melanocytes
Melanocytes from individual foreskin cultures (designated ‘‘823A,’’
‘‘824A,’’ ‘‘1230B’’) were plated in MGM at 105 cells in a six-
well plate. Cells were infected at 2.5 multiplicity of infection
with MISSION Sigma Lentivirus particles expressing shRNA target-
ing two loci of human Plexin B1 (Clones TRCN0000061535 and
TRCN0000061536). Cells infected with nontarget shRNA in
Lentivirus were used as controls. Silenced cells were selected with
puromycin dihydrochloride (Sigma) at a concentration of 2.5 mgml–1.
Silencing was confirmed by reverse transcription–PCR and western
blotting (Supplementary Figure S3 online).
UV irradiation
Cells were maintained in complete media and irradiation was
carried out in sterile phosphate-buffered saline using a bank of six
FS20 sun lamps (Westinghouse, Cranberry Township, PA) that have
475% emission in the UV irradiation range (280–320 nm), with a
peak emission of 313 nm, and o25% UVA rays (4320nm). Schott
WGII filter (ElmsFord, NY) was used to remove UVC rays. Irradiation
times (in seconds) were calculated by multiplying the output of the
FS20 lamps (Watts cm–2) determined using a IL1700 meter (New-
berry Port, MA), by the desired dose (mJ cm–2). This number was
divided by 10. Total irradiation times ranged from 120 seconds
(40mJ cm–2) to 150 seconds (60mJ cm–2).
Western blotting
Cells were lysed in RIPA buffer (150mM NaCl, 1% NP-40, 0.5%
deoxycholate, 0.1% SDS, and 50mM Tris-HCl) with protease
inhibitors (Boehringer Mannheim GmbH, Mannheim, Germany)
and protein was quantified using bovine serum albumin as a standard
(Bio-Rad Laboratories, Hercules, CA). Protein was resolved on
SDS-PAGE gels and blotted using standard procedures. Visualization
Keratinocyte
UVB
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HGF
c-Met
P
P
Melanocyte
membrane
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Figure 6. Proposed model of effects of Semaphorin 4D (Sema4D) on human
melanocytes. The Plexin B1 receptor on the melanocyte membrane binds
Sema4D, which is produced by basal keratinocytes. Plexin B1 signaling
activates Akt and extracellular signal–regulated kinase (Erk)1/Erk2, promoting
melanocyte survival and proliferation, respectively. Exposure of melanocytes
to UVB downregulates Plexin B1 expression, releasing inhibitory signaling on
the c-Met receptor, which is activated by hepatocyte growth factor (HGF)
produced by keratinocytes and fibroblasts. This results in enhanced
c-Met-dependent loss of E-cadherin expression, promoting melanocyte
migration and, potentially, transformation to melanoma.
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of the immunoreactive proteins was accomplished with an enhanced
chemiluminescence reaction (Pierce Chemical).
Immunohistochemical staining
Staining for Sema4D and Plexin B1 was carried out on sections of
normal human adult skin from sun-exposed areas, which were
obtained according to the University of Rochester Research Subjects
Review Board guidelines. Staining for Plexin B1 was performed as
previously described (Stevens et al., 2010). For Sema4D, an identical
protocol was followed, except that slides were incubated in a
different antigen retrieval buffer (sodium citrate pH 6.0) and slides
were incubated with anti-Sema4D mouse mAbs (1/100). Negative
controls consisted of mouse IgG or rabbit IgG (Sigma) instead of the
primary antibody.
CLICK-IT and TUNEL assays
Staining was performed on melanocytes cultured on PurCol-coated
coverslips. Analysis of proliferation was performed using the CLICK-
IT assay (Invitrogen, Carlsbad, CA). TUNEL uptake was detected
using the DeadEnd Flurometric TUNEL System (Promega, Madison,
WI). CLICK-IT- or TUNEL-positive nuclei were visualized using a
filter with excitation wavelength of 495 nm. Positive nuclei were
counted in a minimum of 200 cells, and percent positive nuclei
determined by dividing by total nuclei, identified by 4,6-diamidino-
2-phenylindole counterstaining, and viewed with a filter with
excitation wavelength of 341 nM.
Scratch assay
Melanocytes were plated in full media at a density of 3 105 cells in
a six-well dish and allowed to grow to near confluence (B80%).
Three scratches were made on the bottom of each well using a sterile
200ml pipette tip. Wells were washed gently with phosphate-
buffered saline and replaced with media containing mitomycin C to
prevent proliferation (5 mgml–1; Fisher Scientific, Pittsburg, PA), and
either HGF (10 ngml–1) with Control or HGF (10 ngml–1) with
Sema4D (100 ngml–1). Controls consisted of cells treated with
vehicle alone and mitomycin C. Digital images from an inverted
phase contrast microscope were taken 0 and 24 hours later.
Quantification of migrated cells was performed by counting the
number of cells (defined as cells with nuclei) that migrated from
the edges of the scratches using the ImageJ software, NIH (Bethesda,
MD). Three fields from each scratch (a total of nine fields per
condition) were analyzed, and the numbers were averaged.
Reverse transcription–PCR and comparative real-time PCR
Total RNA was isolated using the RNeasy Mini Kit (QIAgen,
Valencia, CA) according to the manufacturer’s instructions, and
reverse transcription and real-time PCR for Plexin B1 was performed
as previously described (Stevens et al., 2010).
Recombinant Sema4D-Fc
Recombinant human Sema4D was expressed as an Fc-tagged
protein in pEFBos vector (kindly provided by Hitoshi Kikutani,
Osaka University, Osaka, Japan) in 293FT cells (Invitrogen). Sema4D
was purified from culture supernatants as previously described
(McClelland et al., 2011). Protein purity, quantity, and identity were
assessed by silver staining of gels and by western blotting (Supple-
mentary Figure S4 online). Controls consisted of culture supernatants
of 293FT cells that were treated identically as culture supernatants
of transfected cells (‘‘control’’). Specifically, culture supernatants
of untransfected 293FT cells were collected, floating cells were
removed by centrifugation, and supernatant was incubated with
protein-A-conjugated sepharose beads. Following elution from the
beads, the sample was assessed by silver staining of gels and by
western blotting (Supplementary Figure S4 online).
Statistical analysis
Differences between means were analyzed using two-tailed
Student’s t-test. A P-value of o0.05 was considered significant.
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